Bethany Dudek

Bethany Dudek serves as Chief Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT). Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) operates in the research sector with approximately 370.0 employees. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) generates annual revenue of 166000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT).
• • Our database includes 201,469 c suite-level executives.

DNS Made Easy Outlook Adobe Marketing Cloud Salesforce Adobe Media Optimizer Vimeo Linkedin Marketing Solutions Mobile Friendly Google Tag Manager Akamai RUM Cedexis Radar Google Font API reCAPTCHA New Relic WordPress.org Gravity Forms Nginx Varnish Android IoT Data Analytics Remote Basis AI

biotechnology medical dermatology drug development inflammation immunology clinical trials topical drugs bioscience commercialization plaque psoriasis atopic dermatitis eczema biotechnology: pharmaceutical preparations health care biotechnology research innovative treatments immune-mediated skin diseases chronic inflammatory diseases topical therapies pde4 inhibitors zoryve cream zoryve foam seborrheic dermatitis scalp psoriasis chronic hand eczema vitiligo alopecia areata fda approval patient access safety & efficacy treatment options methotrexate biologics topical corticosteroids skin barrier repair patient assistance programs clinical research medical professionals telemedicine solutions patient education personalized dermatology patient care dermatology expertise new drug applications long-term disease management dermatology innovation therapeutic outcomes unmet medical needs disease management medical affairs biotherapeutics scientific publications investigator-initiated trials medical insights adverse effects management drug formulation patient support programs strategic collaborations immune-mediated diseases topical treatments psoriasis jak inhibitors innovative therapies patient-centric fda-approved products dermatological conditions strategic partnerships market positioning patient demographics psychographic segmentation behavioral analysis immuno-dermatology product pipeline zoryve roflumilast collaborations commercial-stage healthcare professionals dermatology market therapeutic innovation patient quality of life scientific research market access financial growth community engagement health wellness & fitness hospital & health care

RM

Rajvir Madan SVP and Chief Digital and Information Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

How can I contact Bethany Dudek?

Bethany Dudek's verified email address is available on MessageCEO. They currently work at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT). Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Bethany Dudek lead?

Bethany Dudek is Chief Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a company in the research sector with 370.0 employees.

What industry is Bethany Dudek in?

Bethany Dudek works in the research industry as Chief Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT). MessageCEO provides verified contact information for executives across all major industries.

Is Bethany Dudek's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Bethany Dudek's profile is kept up-to-date with the latest available information.

Last updated: April 11, 2026